Suppr超能文献

白细胞介素-36受体的结构与功能特性

Structural and Functional Attributes of the Interleukin-36 Receptor.

作者信息

Yi Guanghui, Ybe Joel A, Saha Siddhartha S, Caviness Gary, Raymond Ernest, Ganesan Rajkumar, Mbow M Lamine, Kao C Cheng

机构信息

From the Departments of Molecular and Cellular Biochemistry and.

Environmental Health, School of Public Health, Indiana University, Bloomington, Indiana 47405 and.

出版信息

J Biol Chem. 2016 Aug 5;291(32):16597-609. doi: 10.1074/jbc.M116.723064. Epub 2016 Jun 15.

Abstract

Signal transduction by the IL-36 receptor (IL-36R) is linked to several human diseases. However, the structure and function of the IL-36R is not well understood. A molecular model of the IL-36R complex was generated and a cell-based reporter assay was established to assess the signal transduction of recombinant subunits of the IL-36R. Mutational analyses and functional assays have identified residues of the receptor subunit IL-1Rrp2 needed for cytokine recognition, stable protein expression, disulfide bond formation and glycosylation that are critical for signal transduction. We also observed that, overexpression of ectodomain (ECD) of Il-1Rrp2 or IL-1RAcP exhibited dominant-negative effect on IL-36R signaling. The presence of IL-36 cytokine significantly increased the interaction of IL-1Rrp2 ECD with the co-receptor IL-1RAcP. Finally, we found that single nucleotide polymorphism A471T in the Toll-interleukin 1 receptor domain (TIR) of the IL-1Rrp2 that is present in ∼2% of the human population, down-regulated IL-36R signaling by a decrease of interaction with IL-1RAcP.

摘要

白细胞介素-36受体(IL-36R)介导的信号转导与多种人类疾病相关。然而,IL-36R的结构和功能尚未完全明确。我们构建了IL-36R复合物的分子模型,并建立了基于细胞的报告基因检测方法,以评估IL-36R重组亚基的信号转导。通过突变分析和功能检测,我们确定了受体亚基IL-1Rrp2中对于细胞因子识别、稳定蛋白表达、二硫键形成和糖基化至关重要的残基,这些对于信号转导至关重要。我们还观察到,Il-1Rrp2或IL-1RAcP胞外域(ECD)的过表达对IL-36R信号传导具有显性负效应。IL-36细胞因子的存在显著增加了IL-1Rrp2 ECD与共受体IL-1RAcP的相互作用。最后,我们发现,在约2%的人群中存在的IL-1Rrp2的Toll样白细胞介素1受体结构域(TIR)中的单核苷酸多态性A471T,通过减少与IL-1RAcP的相互作用而下调IL-36R信号传导。

相似文献

1
Structural and Functional Attributes of the Interleukin-36 Receptor.
J Biol Chem. 2016 Aug 5;291(32):16597-609. doi: 10.1074/jbc.M116.723064. Epub 2016 Jun 15.
2
E3 Ubiquitin Ligase RNF125 Activates Interleukin-36 Receptor Signaling and Contributes to Its Turnover.
J Innate Immun. 2018;10(1):56-69. doi: 10.1159/000481210. Epub 2017 Nov 25.
3
Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation.
J Biol Chem. 2018 Jan 12;293(2):403-411. doi: 10.1074/jbc.M117.805739. Epub 2017 Nov 27.
4
Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor.
Front Immunol. 2021 Dec 24;12:779100. doi: 10.3389/fimmu.2021.779100. eCollection 2021.
5
6
Structural insights into the interaction of IL-33 with its receptors.
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14918-23. doi: 10.1073/pnas.1308651110. Epub 2013 Aug 26.
8
The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions.
Immunology. 2022 May;166(1):38-46. doi: 10.1111/imm.13462. Epub 2022 Mar 10.
9
Structural insights into the assembly and activation of IL-1β with its receptors.
Nat Immunol. 2010 Oct;11(10):905-11. doi: 10.1038/ni.1925. Epub 2010 Aug 29.

引用本文的文献

1
The complex roles of IL-36 and IL-38 in cancer: friends or foes?
Oncogene. 2025 Apr;44(13):851-861. doi: 10.1038/s41388-025-03293-4. Epub 2025 Mar 8.
3
Key Interleukins in Inflammatory Bowel Disease-A Review of Recent Studies.
Int J Mol Sci. 2024 Dec 26;26(1):121. doi: 10.3390/ijms26010121.
4
Exploring the role of IL-1β in inflammatory bowel disease pathogenesis.
Front Med (Lausanne). 2024 Jan 22;11:1307394. doi: 10.3389/fmed.2024.1307394. eCollection 2024.
6
New insights on IL‑36 in intestinal inflammation and colorectal cancer (Review).
Exp Ther Med. 2023 Apr 21;25(6):275. doi: 10.3892/etm.2023.11974. eCollection 2023 Jun.
7
Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders.
Eur Cytokine Netw. 2022 Sep 1;33(3):54-69. doi: 10.1684/ecn.2022.0480.
8
IL-1RAP, a Key Therapeutic Target in Cancer.
Int J Mol Sci. 2022 Nov 29;23(23):14918. doi: 10.3390/ijms232314918.
10
IL-36 is Closely Related to Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2022 Jun 7;17:1339-1347. doi: 10.2147/COPD.S357151. eCollection 2022.

本文引用的文献

1
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage.
J Immunol. 2016 Jan 1;196(1):34-8. doi: 10.4049/jimmunol.1501312. Epub 2015 Nov 20.
2
Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor.
J Biol Chem. 2015 Sep 25;290(39):23997-4006. doi: 10.1074/jbc.M115.653378. Epub 2015 Aug 12.
3
The Phyre2 web portal for protein modeling, prediction and analysis.
Nat Protoc. 2015 Jun;10(6):845-58. doi: 10.1038/nprot.2015.053. Epub 2015 May 7.
4
Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions.
J Leukoc Biol. 2015 Apr;97(4):645-52. doi: 10.1189/jlb.3RI1014-495R. Epub 2015 Feb 11.
5
The structural basis for receptor recognition of human interleukin-18.
Nat Commun. 2014 Dec 15;5:5340. doi: 10.1038/ncomms6340.
6
Molecular determinants of agonist and antagonist signaling through the IL-36 receptor.
J Immunol. 2014 Jul 15;193(2):921-30. doi: 10.4049/jimmunol.1400538. Epub 2014 Jun 16.
7
IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.
J Immunol. 2014 Jun 15;192(12):6053-61. doi: 10.4049/jimmunol.1301481. Epub 2014 May 14.
8
Biology of IL-36 cytokines and their role in disease.
Semin Immunol. 2013 Dec 15;25(6):458-65. doi: 10.1016/j.smim.2013.11.003. Epub 2013 Dec 17.
9
The interleukin-1 family: back to the future.
Immunity. 2013 Dec 12;39(6):1003-18. doi: 10.1016/j.immuni.2013.11.010.
10
Structural insights into the interaction of IL-33 with its receptors.
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14918-23. doi: 10.1073/pnas.1308651110. Epub 2013 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验